Free Trial

VYNE Therapeutics (VYNE) News Today

VYNE Therapeutics logo
$2.70 +0.12 (+4.65%)
As of 01/17/2025 04:00 PM Eastern
VYNE Therapeutics Updates Corporate Presentation and Pipeline Progress
VYNE Therapeutics Inc. stock logo
HC Wainwright Reaffirms Buy Rating for VYNE Therapeutics (NASDAQ:VYNE)
HC Wainwright restated a "buy" rating and set a $5.75 price objective on shares of VYNE Therapeutics in a research report on Tuesday.
VYNE Therapeutics (VYNE) Gets a Buy from BTIG
VYNE Therapeutics Inc. stock logo
HC Wainwright Reaffirms "Buy" Rating for VYNE Therapeutics (NASDAQ:VYNE)
HC Wainwright reaffirmed a "buy" rating and issued a $5.75 target price on shares of VYNE Therapeutics in a research note on Monday.
BTIG Initiates a Buy Rating on VYNE Therapeutics (VYNE)
VYNE Therapeutics Reports Encouraging Phase 1a Data For VYN202
VYNE Therapeutics Inc.
VYNE Therapeutics initiated with a Buy at BTIG
VYNE Therapeutics initiated with a Buy at BTIG on I&I potential
VYNE Therapeutics Advances Clinical Pipeline in Q3 2024
VYNE Therapeutics Inc
Get VYNE Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYNE and its competitors with MarketBeat's FREE daily newsletter.

VYNE Media Mentions By Week

VYNE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VYNE
News Sentiment

0.72

0.46

Average
Medical
News Sentiment

VYNE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VYNE Articles
This Week

6

1

VYNE Articles
Average Week

Get VYNE Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYNE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VYNE) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners